Interaction of drug-carrier systems with targets - A study using atomic force microscopy

Pharmazie

Volumn 65, Issue 9, 2010, Pages 657-664

  Blaschke, Tobias ^a   Spangenberg, T ^c   Schlupp, P ^a,b   Dathe, M ^f   Szcymczak, W ^e   Mehnert, W ^a   Korting, H C ^d   Thalhammer, S ^f   Niehus, H ^c   Schafer Korting M ^a   Kramer, K D ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; GLYCEROL PALMITOSTEARATE; MIGLYOL; NANOSTRUCTURED LIPID CARRIER; POLOXAMER; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; ATOMIC FORCE MICROSCOPY; DRUG DELIVERY SYSTEM; MEMBRANE STRUCTURE; MOLECULAR STABILITY;

DRUG CARRIERS; HUMIDITY; INDICATORS AND REAGENTS; LIPIDS; MEMBRANES, ARTIFICIAL; MICROSCOPY, ATOMIC FORCE; PEPTIDES; SPECTROMETRY, FLUORESCENCE; SURFACE-ACTIVE AGENTS;

EID: 77957994110     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.9858     Document Type: Article

References (32)

1. Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H (2004) Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res 21: 1818-1825. (Pubitemid 39390094)
2. Binnig G, Quate CF, Gerber C (1986) Atomic force microscope. Phys Rev Lett 56: 930-933.
3. Braem C, Blaschke T, Panek-Minkin G, Herrmann W, Schlupp P, Paepenmüller T, Müller-Goyman C, Mehnert W, Bittl R, Schäfer-Korting M, Kramer KD (2007) Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance. J Control Release 119: 128-135.
4. Cevc G (2004) Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 56: 675-711.
5. Choi MJ, Maibach HI (2005) Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Physiol 18: 209-219. (Pubitemid 41159952)
6. Dathe M, Meyer J, Beyermann M, Maul B, Hoischen C, Bienert M (2002) General aspects of peptide selectivity towards lipid bilayers and cell membranes studied by variation of the structural parameters of amphipathic helical model peptides. Biochim Biophys Acta 1558: 171-186. (Pubitemid 34075532)
7. Dathe M, Nikolenko H, Meyer J, Beyermann M, Bienert M (2001) Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett 501: 146-150. (Pubitemid 32695480)
8. Fesq H, Lehmann J, Kontny A, Erdmann I, Theiling K, Rother M, Ring J, Cevc G, Abeck D (2003) Improved risk-benefit ratio for topical triamcinolone acetonide in Transfersome in comparison with equipotent cream and ointment: a randomized controlled trial. Br J Dermatol 149: 611-619. (Pubitemid 37281596)
9. Fukuma T, Higgins MJ, Jarvis SP (2007) Direct imaging of individual intrinsic hydration layers on lipid bilayers at Angstrom resolution. Biophys J 92: 3603-3609. (Pubitemid 46698649)
10. Holtze C, Sivaramakrishnan R, Antonietti M, Tsuwi J, Kremer F, Kramer KD (2006) The microwave absorption of emulsions containing aqueous micro-and nanodroplets: A means to optimize micro-wave heating. Colloid Interface Sci 302: 651-657. (Pubitemid 44332406)
11. Jenning V, Gysler A, Schäfer-Korting M, Gohla SH (2000) Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 49: 211-218.
12. Jores K, Mehnert W, Mäder K (2003) Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a nuclear magnetic resonance and electron spin resonance study. Pharm Res 20: 1274-1283.
13. Kristl J, Volk B, Ahlin P, Gombac K, Sentjurc M (2003) Interactions of solid lipid nanoparticles with model membranes and leukocytes studied by EPR. Int J Pharm 256: 133-140.
14. Lee M, Jhe W (2006) General theory of amplitude-modulation atomic force microscopy. Phys Rev Lett 97: 036104-1-036104-4.
15. Lombardi Borgia S, Regehly M, Sivaramakrishnan R, Mehnert W, Korting HC, Danker K, Röder B, Kramer KD, Schäfer-Korting M (2005) Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release 110: 151-163.
16. Manjunath K, Venkateswarlu V (2005) Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Control Release 107: 215-228.
17. Mehnert W, Mäder K (2001) Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47: 165-196.
18. Müller RH, Ruhl D, Runge S, Schulze-Forster K, Mehnert W (1997) Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm Res 14: 458-462.
19. Müller RH, Runge S, Ravelli V, Mehnert W, Thunemann AF, Souto EB (2006) Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals. Int J Pharm 317: 82-89.
20. Santos Maia C, Mehnert W, Schaller M, Korting HC, Gysler A, Haberland A, Schäfer-Korting M (2002) Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 10: 489-495.
21. Sauer I, Dunay IR, Weisgraber K, Bienert M, Dathe M (2005) An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells. Biochemistry 44: 2021-2029.
22. Schäfer-Korting M, Mehnert W, Korting HC (2007) Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 59: 427-443.
23. Schöler N, Hahn H, Müller RH, Liesenfeld O (2002) Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages. Int J Pharm 231: 167-176.
24. Sivaramakrishnan R, Kankate L, Niehus H, Kramer K (2003) Parelectric spectroscopy of drug-carrier systems - distribution of carrier masses or activation. Biophys Chem 114: 221-228.
25. Sivaramakrishnan R, Nakamura C, Mehnert W, Korting HC, Kramer KD, Schäfer-Korting M (2004) Glucocorticoid entrapment into lipid carriers-characterisation by parelectric spectroscopy and influence on dermal uptake. J Control Release 97: 493-502.
26. Spangenberg T, de Mello NF, Creczynski-Pasa TB, Pasa AA, Niehus H (2004) AFM in-situ characterization of supported phospholipids layers formed by solution spreading. Phys Stat Sol 201: 857-868.
27. Stecova J, Mehnert W, Blaschke T, Kleuser B, Sivaramakrishnan R, Zouboulis CC, Seltmann H, Korting HC, Kramer KD, Schäfer-Korting M (2007) Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm Res 24: 991-1000.
28. Thalhammer S, Heckel WM (2004) Atomic Force Microscopy as a tool in nanobiology - Part I: imaging and manipulation in cytogenetics. Cancer Genom Proteom 1: 59-70.
29. Weyenberg W, Filev P, Van den Plas D, Vandervoort J, De Smet K, Sollie P, Ludwig A (2007) Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application. Int J Pharm 337: 291-298.
30. Wissing S, Lippacher A, Müller R (2001) Investigations on the occlusive properties of solid lipid nanoparticles (SLN). J Cosmet Sci 52: 313-324.
31. Wissing SA, Müller RH (2003) The influence of solid lipid nanoparticles on skin hydration and viscoelasticity - in vivo study. Eur J Pharm Biopharm 56: 67-72.
32. Yang S, Zhu J, Lu Y, Liang B, Yang C (1999) Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm Res 16: 751-757.